array:23 [
  "pii" => "S1578219017303049"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2017.10.001"
  "estado" => "S300"
  "fechaPublicacion" => "2017-12-01"
  "aid" => "1769"
  "copyright" => "Elsevier España, S.L.U. and AEDV"
  "copyrightAnyo" => "2017"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2017;108:891"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 436
    "formatos" => array:3 [
      "EPUB" => 22
      "HTML" => 324
      "PDF" => 90
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731017304167"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2017.07.009"
      "estado" => "S300"
      "fechaPublicacion" => "2017-12-01"
      "aid" => "1769"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2017;108:891"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 263
        "formatos" => array:3 [
          "EPUB" => 1
          "HTML" => 182
          "PDF" => 80
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>"
        "titulo" => "Nueva tabla para establecer la gravedad de la psoriasis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "891"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "New Assessment Table for Establishing Severity in Psoriasis"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "D&#46; Vidal"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Vidal"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219017303049"
          "doi" => "10.1016/j.adengl.2017.10.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303049?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017304167?idApp=UINPBA000044"
      "url" => "/00017310/0000010800000010/v1_201711300829/S0001731017304167/v1_201711300829/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S157821901730344X"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.10.023"
    "estado" => "S300"
    "fechaPublicacion" => "2017-12-01"
    "aid" => "1778"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2017;108:892"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 458
      "formatos" => array:3 [
        "EPUB" => 23
        "HTML" => 372
        "PDF" => 63
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
      "titulo" => "Skin Diseases in the Emergency Department&#58; Impact on Patient Quality of Life"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "892"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "La enfermedad dermatol&#243;gica en urgencias y su importante impacto sobre la calidad de vida de los pacientes"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Mart&#237;nez Garc&#237;a"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Mart&#237;nez Garc&#237;a"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731017304702"
        "doi" => "10.1016/j.ad.2017.08.004"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017304702?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730344X?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000010/v1_201711300824/S157821901730344X/v1_201711300824/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
    "titulo" => "New Assessment Table for Establishing Severity in Psoriasis"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "891"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "D&#46; Vidal"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "D&#46;"
            "apellidos" => "Vidal"
            "email" => array:1 [
              0 => "david&#46;vidal&#64;sanitatintegral&#46;org"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital de Sant Joan Desp&#237; Mois&#232;s Broggi&#44; Sant Joan Desp&#237;&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Nueva tabla para establecer la gravedad de la psoriasis"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Psoriasis can be classified as mild&#44; moderate&#44; or severe&#46; Given the great variability in the clinical forms of the disease&#44; many different instruments are currently used to assess severity in these patients&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> However&#44; all of these methods have limitations&#46; Currently&#44; the most used instruments are the Psoriasis Area Severity Index &#40;PASI&#41;&#44; body surface area &#40;BSA&#41;&#44; Investigator&#39;s Global Assessment scale &#40;IGA&#41;&#44; and Dermatology Life Quality Index &#40;DLQI&#41;&#46; In 2005&#44; Finlay proposed the rule of tens &#40;PASI&#44; BSA or DLQI<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>10&#41; as a way to define severe psoriasis&#44;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> but this is far from being a dogma and numerous thresholds and other considerations &#40;prior treatment&#44; site affected&#44; comorbidities&#44; etc&#46;&#41; have been proposed by scientific societies as ways of classifying severity in psoriasis&#46; In recent years&#44; the use of the DLQI has come to the fore&#44;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> and in this issue Llamas-Velasco et al&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">4</span></a> propose a table combining PASI and DLQI as a way to classify severity rapidly and easily in clinical practice&#46; The novel aspect of the proposed classification is that does not require information on the BSA and it only considers psoriasis to be mild if the patient has a PASI score less than 7 and a DLQI score under 5&#46; Only time will tell whether this proposal will prove successful&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Vidal D&#46; Nueva tabla para establecer la gravedad de la psoriasis&#46; Actas Dermosifiliogr&#46; 2017&#59;108&#58;891&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:4 [
            0 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Grupo de Trabajo de Psoriasis de la AEDV&#46; &#191;C&#243;mo se mide la gravedad de la psoriasis&#63; Disponible en&#58; <a href="https://aedv.es/wp-content/uploads/2016/07/Indices-de-medicio%CC%81n-de-psoriasis.pdf">https&#58;&#47;&#47;aedv&#46;es&#47;wp-content&#47;uploads&#47;2016&#47;07&#47;Indices-de-medicio&#37;CC&#37;81n-de-psoriasis&#46;pdf</a>&#46;"
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Current severe psoriasis and the rule of tens"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "A&#46;Y&#46; Finlay"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2133.2005.06502.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2005"
                        "volumen" => "152"
                        "paginaInicial" => "861"
                        "paginaFinal" => "867"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15888138"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Definition of treatment goals for moderate to severe psoriasis&#58; A European consensus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "U&#46; Mrowietz"
                            1 => "K&#46; Kragballe"
                            2 => "K&#46; Reich"
                            3 => "P&#46; Spuls"
                            4 => "C&#46;E&#46; Griffiths"
                            5 => "A&#46; Nast"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00403-010-1080-1"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol Res"
                        "fecha" => "2011"
                        "volumen" => "303"
                        "paginaInicial" => "1"
                        "paginaFinal" => "10"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20857129"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Psoriasis moderada&#46; Propuesta de definici&#243;n"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46; Llamas-Velasco"
                            1 => "P&#46; de la Cueva"
                            2 => "J&#46; Notario"
                            3 => "L&#46; Mart&#237;nez-Pilar"
                            4 => "A&#46; Martorell"
                            5 => "D&#46; Moreno-Ram&#237;rez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2017"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010800000010/v1_201711300824/S1578219017303049/v1_201711300824/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66476"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Commentaries"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000010/v1_201711300824/S1578219017303049/v1_201711300824/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303049?idApp=UINPBA000044"
]
Compartir
Información de la revista
Vol. 108. Núm. 10.
Páginas 891 (diciembre 2017)
Vol. 108. Núm. 10.
Páginas 891 (diciembre 2017)
Commentaries
Acceso a texto completo
New Assessment Table for Establishing Severity in Psoriasis
Nueva tabla para establecer la gravedad de la psoriasis
Visitas
4585
D. Vidal
Servicio de Dermatología, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo

Psoriasis can be classified as mild, moderate, or severe. Given the great variability in the clinical forms of the disease, many different instruments are currently used to assess severity in these patients.1 However, all of these methods have limitations. Currently, the most used instruments are the Psoriasis Area Severity Index (PASI), body surface area (BSA), Investigator's Global Assessment scale (IGA), and Dermatology Life Quality Index (DLQI). In 2005, Finlay proposed the rule of tens (PASI, BSA or DLQI>10) as a way to define severe psoriasis,2 but this is far from being a dogma and numerous thresholds and other considerations (prior treatment, site affected, comorbidities, etc.) have been proposed by scientific societies as ways of classifying severity in psoriasis. In recent years, the use of the DLQI has come to the fore,3 and in this issue Llamas-Velasco et al.4 propose a table combining PASI and DLQI as a way to classify severity rapidly and easily in clinical practice. The novel aspect of the proposed classification is that does not require information on the BSA and it only considers psoriasis to be mild if the patient has a PASI score less than 7 and a DLQI score under 5. Only time will tell whether this proposal will prove successful.

References
[1]
Grupo de Trabajo de Psoriasis de la AEDV. ¿Cómo se mide la gravedad de la psoriasis? Disponible en: https://aedv.es/wp-content/uploads/2016/07/Indices-de-medicio%CC%81n-de-psoriasis.pdf.
[2]
A.Y. Finlay.
Current severe psoriasis and the rule of tens.
Br J Dermatol, 152 (2005), pp. 861-867
[3]
U. Mrowietz, K. Kragballe, K. Reich, P. Spuls, C.E. Griffiths, A. Nast, et al.
Definition of treatment goals for moderate to severe psoriasis: A European consensus.
Arch Dermatol Res, 303 (2011), pp. 1-10
[4]
M. Llamas-Velasco, P. de la Cueva, J. Notario, L. Martínez-Pilar, A. Martorell, D. Moreno-Ramírez.
Psoriasis moderada. Propuesta de definición.
Actas Dermosifiliogr, (2017),

Please cite this article as: Vidal D. Nueva tabla para establecer la gravedad de la psoriasis. Actas Dermosifiliogr. 2017;108:891.

Copyright © 2017. Elsevier España, S.L.U. and AEDV
Descargar PDF
Idiomas
Actas Dermo-Sifiliográficas
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?